• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fas antigen expression in hepatocellular carcinoma tissues.

作者信息

Ito Y, Takeda T, Umeshita K, Sakon M, Wakasa K, Matsuura N, Monden M

机构信息

Department of Surgery II, Osaka University Medical School, Japan.

出版信息

Oncol Rep. 1998 Jan-Feb;5(1):41-4.

PMID:9458289
Abstract

Fas antigen belongs to the tumor necrosis factor receptor family and is known to induce apoptosis. This protein is abundantly expressed in hepatocytes, especially in acute and chronic hepatitis. To elucidate the clinical significance of Fas in hepatocellular carcinoma (HCC), we investigated its expression in 50 HCC having various characteristics. Fas was comprehensively expressed in non-cancerous hepatocytes as well as bile ducts. It was moderately expressed in histiocytes in the stroma rather than in infiltrating lymphocytes. In HCC, Fas expression was significantly reduced when there was poor differentiation (p<0.001), portal tumor thrombus and extracapsular invasion (p<0.05) according to univariate analysis. Multivariate analysis revealed statistical significance between Fas expression and the degree of differentiation (p=0.0002). These results suggest that HCC, like non-cancerous hepatocytes, express Fas antigen, when they are well or moderately differentiated but lose this ability when they become poorly differentiated as the carcinoma advances.

摘要

相似文献

1
Fas antigen expression in hepatocellular carcinoma tissues.
Oncol Rep. 1998 Jan-Feb;5(1):41-4.
2
The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?肝细胞癌中Fas受体和配体系统的改变:肝癌细胞在体内如何逃避宿主的免疫监视?
Hepatology. 1999 Aug;30(2):413-21. doi: 10.1002/hep.510300237.
3
Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues.人肝细胞癌及癌旁组织中Fas抗原表达及其与细胞凋亡的关系。
Am J Pathol. 1996 Aug;149(2):429-37.
4
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.Fas和Fas配体的表达状态可以预测肝细胞癌的复发。
Br J Cancer. 2000 Mar;82(6):1211-7. doi: 10.1054/bjoc.1999.1065.
5
Histological analysis of hepatocellular carcinoma treated by intraarterial combined immunochemotherapy.
Hepatogastroenterology. 1995 Sep-Oct;42(5):561-6.
6
Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells?Fas与Fas配体:在肝细胞癌周围的人肝细胞中强烈共表达;癌症能诱导肿瘤周围细胞自杀吗?
J Pathol. 2000 Jun;191(2):150-3. doi: 10.1002/(SICI)1096-9896(200006)191:2<150::AID-PATH612>3.0.CO;2-I.
7
Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.环氧化酶-2表达与人原发性肝细胞癌中CD4+浸润性T淋巴细胞存在之间的相关性。
Hepatogastroenterology. 2008 Mar-Apr;55(82-83):345-50.
8
Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.Fas及Fas相关分子在人肝细胞癌中的表达
Hum Pathol. 2001 Mar;32(3):250-6. doi: 10.1053/hupa.2001.22769.
9
The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma.干扰素γ受体表达对肝细胞癌逃避宿主免疫监视机制的影响。
Hepatology. 2000 Sep;32(3):491-500. doi: 10.1053/jhep.2000.16470.
10
Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.CXC和CC趋化因子在人类恶性肝脏肿瘤中的表达及功能:γ干扰素诱导的人类单核因子在淋巴细胞向肝细胞癌募集过程中的作用
Hepatology. 1999 Jul;30(1):100-11. doi: 10.1002/hep.510300147.

引用本文的文献

1
Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease.FasL/Fas 轴的破坏可防止慢性肝病中炎症相关的肿瘤发生。
Cell Death Dis. 2019 Feb 8;10(2):115. doi: 10.1038/s41419-019-1391-x.
2
Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells.肝脏库普弗细胞、自然杀伤细胞、自然杀伤T细胞和CD8 CD122 T细胞产生的抗肿瘤免疫。
Clin Dev Immunol. 2011;2011:868345. doi: 10.1155/2011/868345. Epub 2011 Nov 29.
3
Apoptosis as a mechanism for liver disease progression.
细胞凋亡作为肝脏疾病进展的一种机制。
Semin Liver Dis. 2010 Nov;30(4):402-10. doi: 10.1055/s-0030-1267540. Epub 2010 Oct 19.
4
Hepatocyte death: a clear and present danger.肝细胞死亡:一个明显而现实的危险。
Physiol Rev. 2010 Jul;90(3):1165-94. doi: 10.1152/physrev.00061.2009.
5
Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2.Smad3通过下调Bcl-2使肝细胞对凋亡敏感,从而降低肝癌易感性。
Cancer Cell. 2006 Jun;9(6):445-57. doi: 10.1016/j.ccr.2006.04.025.
6
Apoptosis: a mechanism of acute and chronic liver injury.细胞凋亡:急性和慢性肝损伤的一种机制。
Gut. 2005 Jul;54(7):1024-33. doi: 10.1136/gut.2004.053850.
7
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.Fas和Fas配体的表达状态可以预测肝细胞癌的复发。
Br J Cancer. 2000 Mar;82(6):1211-7. doi: 10.1054/bjoc.1999.1065.
8
Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.细胞增殖和凋亡均显著预示肝细胞癌患者无病生存期缩短。
Br J Cancer. 1999 Oct;81(4):747-51. doi: 10.1038/sj.bjc.6690758.